A study for a 64 year old woman who takes Otezla, Gabapentin - from FDA reports

Summary

172 females aged 64 (±5) who take the same drugs are studied. This is a personalized study for a 64 year old female patient who has Arthritis Allergic, Pain - Back. The study is created by eHealthMe based on reports from FDA.



How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

What are the drugs?

What are the conditions?

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Dec, 05, 2018

172 females aged 64 (±5) who take Otezla, Gabapentin are studied.


Number of reports submitted per year:

Otezla, Gabapentin for a 64-year old woman.

Information of the patient in this study:

  • Age: 64
  • Gender: female
  • Conditions: Arthritis Allergic, Pain - Back
  • Drugs taken:
    • Otezla (apremilast)
    • Gabapentin (gabapentin)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhea
  3. Viral upper respiratory tract infection
  4. Influenza like illness
  5. Initial insomnia (feeling of inadequate or poor-quality sleep)
  6. Stress and anxiety
  7. Depression
  8. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  9. Upper respiratory tract congestion
  10. Nausea and vomiting
1 - 6 months:
  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Diarrhea
  3. Nausea (feeling of having an urge to vomit)
  4. Drug ineffective
  5. Headache (pain in head)
  6. Nausea and vomiting
  7. Movement - uncontrolled or slow
  8. Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
  9. Weight decreased
  10. Hyperhidrosis (abnormally increased sweating)
6 - 12 months:
  1. Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  2. Night sweats (sweating in night)
  3. Hypersensitivity
  4. Gastric ulcer (stomach ulcer)
  5. Drug ineffective
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Renal disorder (kidney disease)
  9. Abnormal loss of weight
  10. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
1 - 2 years:
  1. Rashes (redness)
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
  4. Nausea and vomiting
  5. Rash pruritic (redness with itching)
  6. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  7. Nausea (feeling of having an urge to vomit)
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Weight increased
  2. Feeling abnormal
  3. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Urinary tract infection
  6. Drug hypersensitivity
  7. Immobile (not moving)
  8. Glaucoma (increased fluid pressure in the eye with vision loss)
  9. Gait disturbance
  10. Oedema peripheral (superficial swelling)

Top conditions involved for these people *:

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 90 people, 52.33%
  2. Psoriasis (immune-mediated disease that affects the skin): 74 people, 43.02%
  3. High Blood Pressure : 17 people, 9.88%
  4. Supplementation Therapy : 12 people, 6.98%
  5. Depression : 11 people, 6.40%
  6. Neuropathy Peripheral (surface nerve damage): 8 people, 4.65%
  7. Stress And Anxiety : 7 people, 4.07%
  8. High Blood Cholesterol : 7 people, 4.07%
  9. Diabetes : 6 people, 3.49%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 3.49%

Top co-used drugs for these people *:

  1. Metformin (29 people, 16.86%)
  2. Vitamin D (21 people, 12.21%)
  3. Oxycodone (19 people, 11.05%)
  4. Cymbalta (18 people, 10.47%)
  5. Potassium (15 people, 8.72%)
  6. Celebrex (14 people, 8.14%)
  7. Synthroid (13 people, 7.56%)
  8. Plaquenil (12 people, 6.98%)
  9. Nexium (12 people, 6.98%)
  10. Vitamin B12 (11 people, 6.40%)

* Some reports may have incomplete information.

What is next?

You are not alone:


Related publications that referenced our studies



Related studies:



FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.